{"log_id": 2788637424573439881, "direction": 0, "words_result_num": 32, "words_result": [{"probability": {"variance": 0, "average": 0.753431, "min": 0.753431}, "location": {"width": 32, "top": 84, "height": 32, "left": 1156}, "words": "国"}, {"probability": {"variance": 0.000111, "average": 0.997228, "min": 0.934797}, "location": {"width": 789, "top": 170, "height": 42, "left": 265}, "words": "用卵泡大小做标准是因为排卵前卵泡的大小已被确认。E2标准代表正常自然排卵周"}, {"probability": {"variance": 6e-05, "average": 0.99632, "min": 0.961711}, "location": {"width": 830, "top": 216, "height": 44, "left": 222}, "words": "期的排卵前期E2水平的下限。P4水平的标准是正常自然排卵周期黄体中期已被确认血清"}, {"probability": {"variance": 0.000599, "average": 0.990727, "min": 0.886314}, "location": {"width": 828, "top": 264, "height": 42, "left": 222}, "words": "P4的下限。因此,如果符合全部三项标准,卵泡发育及排卵会与受孕一致。因OHSS风"}, {"probability": {"variance": 6e-06, "average": 0.998014, "min": 0.99067}, "location": {"width": 832, "top": 311, "height": 43, "left": 220}, "words": "险而终止治疗及获得妊娠的患者被计入卵泡发育成功之列,无论其是否符合卵泡发育标"}, {"probability": {"variance": 0, "average": 0.999485, "min": 0.999485}, "location": {"width": 25, "top": 361, "height": 24, "left": 220}, "words": "准"}, {"probability": {"variance": 8.4e-05, "average": 0.995317, "min": 0.955625}, "location": {"width": 790, "top": 405, "height": 40, "left": 259}, "words": "这五项对照研究的数据包括共计170例患者中的271个治疗周期及107例低LH患者(血"}, {"probability": {"variance": 0.000788, "average": 0.989285, "min": 0.833332}, "location": {"width": 832, "top": 451, "height": 40, "left": 218}, "words": "清LH<1.2IU/L)中的152个治疗周期。在这些研究中,计划生育的154例患者中有48例妊"}, {"probability": {"variance": 0.000784, "average": 0.99132, "min": 0.846025}, "location": {"width": 834, "top": 497, "height": 41, "left": 217}, "words": "娠及39例临床妊娠。94例计划生育的低LH患者中有22例妊娠及15例临床妊娠。在低LH"}, {"probability": {"variance": 0.000336, "average": 0.994912, "min": 0.882994}, "location": {"width": 833, "top": 544, "height": 42, "left": 216}, "words": "亚群及计划怀孕的所有患者群体中按周期及按照患者计算的妊娠率及临床妊娠率在75IU"}, {"probability": {"variance": 0.009716, "average": 0.956894, "min": 0.538594}, "location": {"width": 834, "top": 592, "height": 40, "left": 215}, "words": "rhLH剂量组中最高。75IUr-hLH治疗组按患者计算的临床妊娠率(28%)高于安慰剂组/OIU"}, {"probability": {"variance": 0.000689, "average": 0.985488, "min": 0.891998}, "location": {"width": 465, "top": 640, "height": 30, "left": 219}, "words": "-hH组(12.2%)且具有显著的统计学意义(p=0.04"}, {"probability": {"variance": 1e-05, "average": 0.997012, "min": 0.989947}, "location": {"width": 147, "top": 701, "height": 26, "left": 256}, "words": "国内的临床试验"}, {"probability": {"variance": 0.000265, "average": 0.992928, "min": 0.914574}, "location": {"width": 786, "top": 761, "height": 40, "left": 255}, "words": "国内分别在6个临床研究中心、共30例严重缺乏LH和FSH(低促性腺性性腺功能减退)"}, {"probability": {"variance": 0.001547, "average": 0.987042, "min": 0.771906}, "location": {"width": 833, "top": 807, "height": 41, "left": 212}, "words": "的妇女中进行了一项多中心开放临床研究,验证每日皮下注射75IU的重组人促黄体激素a对"}, {"probability": {"variance": 0.001652, "average": 0.986696, "min": 0.732466}, "location": {"width": 833, "top": 854, "height": 41, "left": 211}, "words": "低促性腺性性腺功能减退症的妇女同时接受150IU的FSH皮下注射对卵泡发育的辅助刺激作用"}, {"probability": {"variance": 4e-06, "average": 0.99853, "min": 0.993927}, "location": {"width": 145, "top": 901, "height": 26, "left": 212}, "words": "和使用的安全性"}, {"probability": {"variance": 0.000103, "average": 0.996956, "min": 0.946574}, "location": {"width": 540, "top": 938, "height": 37, "left": 250}, "words": "主要疗效指标为达到适当的卵泡发育,主要用三个标准界定"}, {"probability": {"variance": 0.000373, "average": 0.988759, "min": 0.921881}, "location": {"width": 323, "top": 970, "height": 32, "left": 256}, "words": "()至少有一个卵泡直径大于17m"}, {"probability": {"variance": 0.03751, "average": 0.853311, "min": 0.57963}, "location": {"width": 208, "top": 947, "height": 62, "left": 700}, "words": "隐医药"}, {"probability": {"variance": 0.00315, "average": 0.976019, "min": 0.727057}, "location": {"width": 420, "top": 1004, "height": 29, "left": 251}, "words": "(ii)注射hCG当天血清E2水平大于109pg/ml"}, {"probability": {"variance": 0, "average": 0.719198, "min": 0.719198}, "location": {"width": 43, "top": 984, "height": 42, "left": 890}, "words": "交"}, {"probability": {"variance": 0.008729, "average": 0.96298, "min": 0.614196}, "location": {"width": 761, "top": 1031, "height": 42, "left": 252}, "words": "(ii)因为担心会发生卵巢过度刺激综合征而没有注射H的受试者和妊娠的受试者"}, {"probability": {"variance": 0.000438, "average": 0.991918, "min": 0.887015}, "location": {"width": 774, "top": 1084, "height": 44, "left": 248}, "words": "入组的31例患者在整个试验过程中,均接受了治疗剂量的药物并完成了整个治疗周期"}, {"probability": {"variance": 6.9e-05, "average": 0.997517, "min": 0.946059}, "location": {"width": 836, "top": 1132, "height": 41, "left": 206}, "words": "在试验过程中未出现不良事件,且在血常规、血生化和尿常规等实验室检查结果中,均未出现"}, {"probability": {"variance": 7e-06, "average": 0.998303, "min": 0.986241}, "location": {"width": 836, "top": 1179, "height": 40, "left": 205}, "words": "有临床意义的异常变化。在符合方案集的30例病例中,23例达到疗效指标,9例达到临床妊"}, {"probability": {"variance": 1e-05, "average": 0.997804, "min": 0.988447}, "location": {"width": 403, "top": 1225, "height": 34, "left": 204}, "words": "娠,有效率为76.7%,临床妊娠率为30.0%"}, {"probability": {"variance": 3e-06, "average": 0.998212, "min": 0.994836}, "location": {"width": 113, "top": 1353, "height": 25, "left": 210}, "words": "【药理毒理】"}, {"probability": {"variance": 3e-06, "average": 0.997885, "min": 0.995265}, "location": {"width": 85, "top": 1399, "height": 25, "left": 202}, "words": "药理作用"}, {"probability": {"variance": 0.004267, "average": 0.975389, "min": 0.621836}, "location": {"width": 792, "top": 1446, "height": 40, "left": 242}, "words": "重组人促黄体激素a(r-hLH)是采用基因工程技术获得的一种糖蛋白,能与卵巢膜(及"}, {"probability": {"variance": 0.00444, "average": 0.979294, "min": 0.622846}, "location": {"width": 837, "top": 1492, "height": 40, "left": 200}, "words": "粒层)和睾丸间质细胞膜上的黄体素/绒毛膜促性腺激素(LH/CG)受体结合。在卵泡期,LH刺"}, {"probability": {"variance": 0.000109, "average": 0.996398, "min": 0.930834}, "location": {"width": 840, "top": 1540, "height": 42, "left": 197}, "words": "激卵巢膜细胞分泌雄激素,可被粒层细胞用来合成雌二醇,以支持卵泡刺激素FSH诱导的卵泡"}], "language": 3}